A validated Ultra HPLC-MS/MS method for determination of TQ-B3203 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of separation science"
DOI: 10.1002/jssc.202001023
Abstract: TQ-B3203 is a new topoisomerase I inhibitor derived from camptothecin. In this paper, a simple and reliable ultra high performance liquid chromatography-tandem mass spectrometric method was developed and validated for determination of TQ-B3203 in human… read more here.
Keywords: plasma; b3203 human; human plasma; determination b3203 ... See more keywords